Obsessive-Compulsive Disorder

Trials

74 participants · First posted Nov 3, 1999

Completed

NCT00000384

Treatment of Obsessive-Compulsive Disorder (OCD) in Children

First posted Nov 3, 1999

Active, not recruiting

NCT05546658

Effects of Psilocybin in Obsessive Compulsive Disorder

35 participants · First posted Sep 21, 2022

Drugs

View all 279 →

small molecule therapeutic for autism/obsessive compulsive disorder (Rugen Therapeutics/Allergan)

Small Molecule

Approved

Fluvoxamine(Luvox)

Manufacturer: Jazz pharmaceuticals, Actavis elizabeth llc +13 more

Conditions: Bulimia Nervosa, Major Depressive Disorder (MDD) +1 more

C₁₅H₂₁F₃N₂O₂ · Rx

Small Molecule

Approved

Clomipramine(Anafranil)

Conditions: Depression, Obsessive Compulsive Disorder (OCD) +1 more

C₁₉H₂₃ClN₂ · Rx

Organizations

View all 17 →

Brainsway

Israel

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Vanda Pharmaceuticals

United States

News

View all 3436 →

last year

AI-Designed Drug for Alzheimer's Psychosis Enters Clinical Trials

last year

Biohaven Advances Troriluzole in Phase 2/3 Trial for Treatment-Resistant OCD as Pipeline Expands

last year

Trials

Treatment of Obsessive-Compulsive Disorder

Treatment of Obsessive-Compulsive Disorder (OCD) in Children

Effects of Psilocybin in Obsessive Compulsive Disorder

Drugs

small molecule therapeutic for autism/obsessive compulsive disorder (Rugen Therapeutics/Allergan)

Fluvoxamine(Luvox)

Clomipramine(Anafranil)

Organizations

Brainsway

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

Vanda Pharmaceuticals

News

AI-Designed Drug for Alzheimer's Psychosis Enters Clinical Trials

Biohaven Advances Troriluzole in Phase 2/3 Trial for Treatment-Resistant OCD as Pipeline Expands

Internet-Based CBT Shows Promise in Treating OCD During COVID-19 Pandemic